« poprzedni post | |
Path: news-archive.icm.edu.pl!pingwin.icm.edu.pl!news.icm.edu.pl!mimuw.edu.pl!news.mi muw.edu.pl!newsfeed.tpinternet.pl!atlantis.news.tpi.pl!news.tpi.pl!not-for-mail From: "Daniel Paprocki" <d...@p...com.pl> Newsgroups: pl.sci.medycyna Subject: Re: Ospamox, Augmentin... Date: Thu, 13 Feb 2003 22:07:58 +0100 Organization: tp.internet - http://www.tpi.pl/ Lines: 18 Message-ID: <b2h1fn$k1r$1@atlantis.news.tpi.pl> References: <b28mu8$j25$1@news.onet.pl> <b2b97q$i4r$1@news.onet.pl> NNTP-Posting-Host: pc85.opole.cvx.ppp.tpnet.pl X-Trace: atlantis.news.tpi.pl 1045170488 20539 213.76.6.85 (13 Feb 2003 21:08:08 GMT) X-Complaints-To: u...@t...pl NNTP-Posting-Date: Thu, 13 Feb 2003 21:08:08 +0000 (UTC) X-Priority: 3 X-MSMail-Priority: Normal X-Newsreader: Microsoft Outlook Express 6.00.2800.1106 X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2800.1106 Xref: news-archive.icm.edu.pl pl.sci.medycyna:99269 Ukryj nagłówki To nieprawda! Polfa Tarchomin produkuje Amotaks w tabletkach 1g (16szt.) w |
Zobacz także